EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lipotoxicity Amplifies IL‐6 Trans‐Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury

Yasuhiko Ueda, Nao Kawaguchi, Yosuke Inomata iD, Jun Arima, Mitsuaki Ishida iD, Yuko Ito, Sang-Woong Lee, Kohei Taniguchi iD

Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3587-3599

DOI: 10.1111/jgh.70782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 28.09.2026. Verfasst von Yasuhiko Ueda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan. Hauptthemen laut MEDLINE: Signal Transduction, Interleukin-6, Endothelial Cells, Palmitic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects approximately 25% of the global population and is a major health concern. Liver sinusoidal endothelial cells (LSECs) undergo morphological and functional alterations during MASLD progression, resulting in endotheliopathy characterized by pro‐inflammatory phenotypes. We hypothesize that lipotoxicity synergistically exacerbates LSEC dysfunction in MASLD via IL‐6 trans‐signaling.

Methods

Human adipocytes were treated with palmitic acid (PA). Human LSECs were treated with PA and the IL‐6/soluble IL‐6 receptor (sIL‐6R) complex. Western blotting, qRT‐PCR, RNA sequencing, transwell assays, and immunofluorescence were performed to examine inflammatory responses. MASLD model mice were established using a choline‐deficient, L‐amino acid‐defined, high‐fat diet (CDAHFD) to validate the in vivo results. Alterations in LSEC morphology were examined by western blotting, histology, and electron microscopy.

Results

PA promoted IL‐6 secretion from adipocytes. In LSECs, PA increased NFκB phosphorylation, whereas co‐stimulation with PA and IL‐6/sIL‐6R complex synergistically enhanced activator of transcription 3 (STAT3) phosphorylation and upregulated inflammatory cytokines, chemokines, and adhesion molecules, including VCAM1. Furthermore, RNA sequencing showed concurrent NFκB and Janus kinase (JAK)/STAT pathway activation. This synergistic effect promoted neutrophil migration and VCAM1 expression under in vitro conditions. In the MASLD mouse model, hepatic IL‐6 expression was elevated, accompanied by steatosis, increased transaminase levels, and inflammatory cell infiltration, along with increased VCAM1 expression and sinusoidal capillarization characterized by upregulated CD34 and downregulated CD32b and LYVE‐1.

Conclusion

Lipotoxicity‐amplified IL‐6 trans‐signaling synergistically exacerbates LSEC endotheliopathy and promotes leukocyte recruitment and liver injury, contributing to MASLD progression and providing novel insights into its pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionInterleukin-6Endothelial CellsPalmitic AcidLiverAdipocytesFatty LiverAnimalsHumansSTAT3 Transcription FactorReceptors, Interleukin-6Disease Models, AnimalCells, CulturedNF-kappa BPhosphorylationMiceMale

Stichwörter der Autor:innen

JAK/STAT pathwayMASLDNFκB pathwayTLR4 signalingsaturated fatty acids

Substanzen

Interleukin-6Palmitic AcidSTAT3 Transcription FactorReceptors, Interleukin-6NF-kappa B

Autor:innen und Institutionen

  • Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Center for Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan.

ORCID-Profile: Yosuke Inomata, Mitsuaki Ishida, Kohei Taniguchi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ueda, Y., Kawaguchi, N., Inomata, Y., Arima, J., Ishida, M., Ito, Y., Lee, S. W., & Taniguchi, K. (2026). Lipotoxicity Amplifies IL‐6 Trans‐Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury. Journal of Gastroenterology and Hepatology, 41(11), 3587-3599. https://doi.org/10.1111/jgh.70782

Vancouver

Ueda Y, Kawaguchi N, Inomata Y, Arima J, Ishida M, Ito Y, et al. Lipotoxicity Amplifies IL‐6 Trans‐Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury. Journal of Gastroenterology and Hepatology. 2026;41(11):3587-3599. doi:10.1111/jgh.70782

BibTeX
@article{Ueda2026,
  author = {Ueda, Yasuhiko and Kawaguchi, Nao and Inomata, Yosuke and Arima, Jun and Ishida, Mitsuaki and Ito, Yuko and Lee, Sang-Woong and Taniguchi, Kohei},
  title = {Lipotoxicity Amplifies IL‐6 Trans‐Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {3587--3599},
  doi = {10.1111/jgh.70782}
}
Kostenlos starten →